Superior Capsule vs Bridging Study (SCR)

July 6, 2021 updated by: University of Calgary

Graft Reconstruction for Irreparable Rotator Cuff Tears: Superior Capsule Reconstruction or Tendon Repair With Graft Interposition

Randomized controlled trial examining superior capsule reconstruction versus tendon repair with graft interposition in "irreparable" rotator cuff tears.

Study Overview

Status

Completed

Conditions

Detailed Description

RCT n = 50

Groups:

  1. bridging
  2. SCR

Outcomes:

  1. WORC
  2. ASES
  3. QuickDASH
  4. MRI at 12 months post-op

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Large to massive rotator cuff tear (with or without subscapularis tear) that may possibly be irreparable without the use of graft materials (confirmed intra-operatively)
  2. Either primary tear or re-tear after previous repair
  3. Radiographic evidence of Hamada stage 1-3, with or without Samilson & Prieto mild osteoarthritis (<3mm inferior osteophyte)

Exclusion Criteria:

  1. Primary glenohumeral osteoarthritis: radiographic evidence of Samilson & Prieto classification moderate or greater
  2. Cuff tear arthropathy (CTA): radiographic evidence of Hamada stage 4 or above
  3. Inflammatory joint disease of the shoulder (e.g. rheumatoid arthritis)
  4. Medical issues precluding surgery
  5. Unwilling or unable to complete study outcomes
  6. Worker's Compensation Claim or litigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bridging
Tendon repair with graft interposition
Tendon repair with graft interposition
Experimental: SCR
Superior Capsule reconstruction
Superior Capsule reconstruction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 24 months
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
24 months
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 12 months
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
12 months
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 6 months
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
6 months
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 3 months
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario Rotator Cuff Index
Time Frame: 24 months
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
24 months
Western Ontario Rotator Cuff Index
Time Frame: 12 months
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
12 months
Western Ontario Rotator Cuff Index
Time Frame: 6 months
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
6 months
Western Ontario Rotator Cuff Index
Time Frame: 3 months
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
3 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 24 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
24 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 12 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
12 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 6 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
6 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 3 months
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
3 months
Tendon healing, assessed via MRI
Time Frame: 12 months
Tendon healing (classifications: intact or retorn)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

November 7, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

June 21, 2021

First Submitted That Met QC Criteria

July 6, 2021

First Posted (Actual)

July 16, 2021

Study Record Updates

Last Update Posted (Actual)

July 16, 2021

Last Update Submitted That Met QC Criteria

July 6, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • REB15-1787

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to share individual participant data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on Bridging

Subscribe